Da, apsolutno! To je jedina razumna odluka, svaka dalja diskusija je – izlišna
Da, pod uslovom da je ta vakcina odobrena za primjenu u EU tj. nije varijanta za zemlje 3. svijeta
Ne, nemam povjerenja u efikasnost prebrzo razvijene vakcine/ nepoznati dugoročni efekti po zdravlje
Ne, nisam pristalica vakcinisanja generalno, kao vida zaštite od bolesti
Ne znam. Lomim se oko odluke
Ko ima oči da vidi vidjeće da 'fektčeking' mašinerija nije u službi istine... već njene modifikacije prema korporativnim interesima. Ovo je jedan djelić te grozne i bolne stvarnosti:
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Rapid Response:
Open letter from The BMJ to Mark Zuckerberg
Dear Mark Zuckerberg,
We are Fiona Godlee and Kamran Abbasi, editors of The BMJ, one of the world’s oldest and most influential general medical journals. We are writing to raise serious concerns about the “fact checking” being undertaken by third party providers on behalf of Facebook/Meta.
In September, a former employee of Ventavia, a contract research company helping carry out the main Pfizer covid-19 vaccine trial, began providing The BMJ with dozens of internal company documents, photos, audio recordings, and emails. These materials revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety. We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites.
The BMJ commissioned an investigative reporter to write up the story for our journal. The article was published on 2 November, following legal review, external peer review and subject to The BMJ’s usual high level editorial oversight and review.[1]
But from November 10, readers began reporting a variety of problems when trying to share our article. Some reported being unable to share it. Many others reported having their posts flagged with a warning about “Missing context ... Independent fact-checkers say this information could mislead people.” Those trying to post the article were informed by Facebook that people who repeatedly share “false information” might have their posts moved lower in Facebook’s News Feed. Group administrators where the article was shared received messages from Facebook informing them that such posts were “partly false.”
Readers were directed to a “fact check” performed by a Facebook contractor named Lead Stories.[2]
We find the “fact check” performed by Lead Stories to be inaccurate, incompetent and irresponsible.
- It fails to provide any assertions of fact that The BMJ article got wrong
- It has a nonsensical title: “Fact Check: The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials”
- The first paragraph inaccurately labels The BMJ a “news blog”
- It contains a screenshot of our article with a stamp over it stating “Flaws Reviewed,” despite the Lead Stories article not identifying anything false or untrue in The BMJ article
- It published the story on its website under a URL that contains the phrase “hoax-alert”
We have contacted Lead Stories, but they refuse to change anything about their article or actions that have led to Facebook flagging our article.
We have also contacted Facebook directly, requesting immediate removal of the “fact checking” label and any link to the Lead Stories article, thereby allowing our readers to freely share the article on your platform.
There is also a wider concern that we wish to raise. We are aware that The BMJ is not the only high quality information provider to have been affected by the incompetence of Meta’s fact checking regime. To give one other example, we would highlight the treatment by Instagram (also owned by Meta) of Cochrane, the international provider of high quality systematic reviews of the medical evidence.[3] Rather than investing a proportion of Meta’s substantial profits to help ensure the accuracy of medical information shared through social media, you have apparently delegated responsibility to people incompetent in carrying out this crucial task. Fact checking has been a staple of good journalism for decades. What has happened in this instance should be of concern to anyone who values and relies on sources such as The BMJ.
We hope you will act swiftly: specifically to correct the error relating to The BMJ’s article and to review the processes that led to the error; and generally to reconsider your investment in and approach to fact checking overall.
Best wishes,
Fiona Godlee, editor in chief
Kamran Abbasi, incoming editor in chief
The BMJ
Competing interests:
As current and incoming editors in chief, we are responsible for everything The BMJ contains.
https://www.bmj.com/content/375/bmj.n2635/rr-80
_____________________
Pa kaže
Facebook admits the truth: ‘Fact checks’ are really just (lefty) opinion
Facebook finally admitted the truth: The “fact checks” that social media use to police what Americans read and watch are just “opinion.”
That’s thanks to a lawsuit brought by celebrated journalist John Stossel, which has exposed the left’s supposed battle against “misinformation” as a farce.
https://nypost.com/2021/12/14/facebo...lefty-opinion/
The more things change, the more they stay the same.
Đe u PG primit fajzera kao booster dozu, a da nije gužva i da je kulturno (ne bih po marketima stvarno se vakcinisao).
AZ dupla doza kod mene i gospođe, prije možda malo manje od dva mjeseca smo bili ok sa antitijelima, ali ajde da odradimo boost, rekao bih da može da pomogne za ne daj bože, a možba bi i išli malo vani, a prošlo je 6 mjeseci od revakcine.
Sent from my Redmi Note 8 Pro using Tapatalk
vojno medicinski centar samo pođi tipa oko 17h. pisale su Vijesti da tamo ima Fajzera
Sent from my M2101K9AG using Tapatalk
“Да, что-то чуждое, бесовское и прелестное есть в ней”
1 year later
VIDEO: Predstavljena COVID propusnica u obliku mikročipa koji se usađuje u ruku, pogledajte kako radi
Stockholm | 17 Dec 2021
Start-up tvrtka Epicenter iz Stockholma u Švedskoj predstavila je novi način nošenja COVID propusnice - ugradnjom mikročipa ispod kože.
Tako implantiranu COVID propusnicu mogao bi očitati bilo koji uređaj koji u sebi sadrži NFC (engl. near-field communication) tehnologiju, koja se koristi za plaćanja bez kontakta te otključavanja vrata bez ključeva.
Implantati su vrlo svestrana tehnologija koja se može koristiti na mnogo različitih načina i trenutačno je vrlo zgodno imati COVID putovnicu uvijek dostupnu na vlastitom implantatu, rekao je Sjöblad u izjavi.
Cjepiva protiv bolesti COVID-19 su se krajem 2020. godine počela distribuirati diljem svijeta, a u drugoj polovici 2021. velik dio svjetskih zemalja uveo je COVID putovnice ili propusnice, bez kojih ljudi više ne mogu prisustvovati određenim događajima, odlaziti u javne institucije ili putovati izvan zemlje.
U Epicenteru su željeli informacije s COVID propusnice učiniti što dostupnijima.
Cool, baš je zgodno.
___________________________
Od ostalih vijesti:
Poor Billy otkazao Božić a ima i poruku za sve nas (nevezano za vakcinalni status):
The more things change, the more they stay the same.
She is only here to annoy herself!
Kada stizu ove Evropske potvrde, na e-zdravlje jos daju stare?
od 24.12.
nothing comes from violence and nothing ever could
Nigerija uništava milon doza doniranih vakcina kojima ističe rok trajanja
Reuters
Šta je čini naše ministarstvo sa isteklom fajzericom, produžilo joj rok?
The more things change, the more they stay the same.
Proizvođač obavlja ispitivanja proizvoda (u ovom slučaju vakcine) i utvrdi da se, ako se proizvod čuva na propisan način, stabilnost i bezbjednost proizvoda ne mijenjaju.
Nakon toga proizvođač podnese zahtjev za produženje roka za upotrebu nadležnim agencijama (američkoj FDA i evropskoj EMA), te agencije pregledaju dokumentaciju i izdaju dozvolu za produženje roka. Potom proizvođač kontaktira lokalne regulatorne agencije (kod nas Institut za ljekove i medicinska sredstva) i oni shodno regulativi odobre traženo produženje roka. Ministarstvo zdravlja tu ima najmanju ulogu.
U Evropi je produženje roka odobreno još u septembru.
Ako proizvođač kaže da se konkretno ova vakcina daje u dozi od 30 mikrograma pri čemu individua ne može da bira hoće li da primi pola te doze ili možda dvije odjednom, onda mislim da možemo da budemo relaksirani i kad je u pitanju datum upotrebe vakcine jer nije proizvoljno određen.
Lijepo je to @Džek birokratskom spikom poentirao da je proizvođač - alfa i omega - iznad svih regulatora, instituta, agencija, država.... Proizvođača se pita kako će se pandemija razvijati, koliko doza će biti potrebno i koji interval između istih je optimalan. Proizvođač je svetinja.
____________________________
Sve više zemalja skraćuje booster interval na 3 mjeseca
The more things change, the more they stay the same.
Proizviđačevo je da pita, a tih silnih agencija i regulatornih tijela da kažu neću. Ako misle da treba.
- .- - .- - .- - .. .-. .- -- --- ... -. .--- .. -.-. .... .- .-. ..
hoćeš da kažeš da je lažna vijest u pitanju?
She is only here to annoy herself!
pa ne treba ti vremena da trošiš jer imaš link u samom tweetu (medrxiv - valjda ti je jasno šta je to)
She is only here to annoy herself!
Last edited by starwalker; 26-12-21 at 14:29.
The more things change, the more they stay the same.
Ista ta Danska testira opsežno, više ne samo od nas nego i od npr Velike Britanije, SAD, Izraela itd. Ovih dana su testirali prosječno 35 osoba na 1000 stanovnika. Da napravimo poređenje s nama, da smo mi isto tako radili, imali bi dnevno oko 20000 testova. Mi ipak testiramo oko 2000-3000 ljudi dnevno, osam do deset puta manje. Odnosno, da smo više testirali, umjesto današnjih 500 pozitivnih, otkrili bi makar još toliko.
Ista ta Danska ovih dana ima ispod 100 covid pacijenata na milion stanovnika u bolnicama. Kod nas je prethodnih sedmica situacija kudikamo bolja nego ranije, ali i dalje imamo oko 250 covid hospitalizovanih pacijenata na milion stanovnika.
Vakcine rade, pomirite se s tim.
Pricam sa drugom.. primio 'samo' 3 vakcine do sad... mora jos dvije da bi mogao da putuje vanka...
Kakvo ludilo mozga.
--------------------------
Do Not Disturb.
--------------------------
Što ono vele fektčekeri - misleading. Omikron je dominantan soj u visoko provakcinisanoj DK a delta u CG, te u tim okolnostima govorimo o dvije različite pandemije što se tiče hospitalizacije. Plus, nepodnošljivom lakoćom uzastopno dovodiš u istu ravan zdravstvo nordijskih kraljevina i zdravstvo tranzicione državice na periferiji Evrope, s med. centrima reliktima komunističke ere... Baš idealno za poređenje hospitalizacija, smrtnosti, izlječenja.. ali kapiram da se u igri odbrane svetinja više ne pita za logiku.
DK je na temu uvedena kao primjer neefikasnosti boostera kod novog soja:
Original antigenic sinthe bad news is that it increasingly looks like the variant that original antigenic sin (OAS) begot and this means that the vaccinated may be wide open for it in a way they would not have been had these programs not been rolled out. worse, they may NEVER be able to generate sound immunity because that’s what OAS does.
https://en.wikipedia.org/wiki/Original_antigenic_sin
Zgodan mit za vjernike dok se u pozadini boost interval skraćuje na 3 mjeseca.
Ipak, sretna okolnost je ta da za sada bosterovana i zero vax populacija imaju jednaku kliničku sliku kod omikrona.
_________________________
Nikad dosta ove vijesti:
Medical Journal Blasts Facebook For Using Fake ‘Fact Checks’ To Justify Censorship
Last edited by starwalker; 26-12-21 at 23:58.
The more things change, the more they stay the same.
Usput bi, iz nekog razloga, bilo jedno 20-30% više mrtvih od od hroničnih bolesti, od staorsti, od srčanog udara, od moždanog. Pod uslovom da se koliko-toliko poštuju mjere.
- .- - .- - .- - .. .-. .- -- --- ... -. .--- .. -.-. .... .- .-. ..
više naučnika upozorava da postoji velika mogućnost da je lijek molnupiravir doveo do omikrona
https://www.forbes.com/sites/william...h=31e6e6e71bc1
Molnupiravir-induced
The final theory, and perhaps the most troubling one, is that Omicron is a result of our own doing, through the treatment of a Covid-19 patient with the highly mutagenic antiviral drug molnupiravir. Molnupiravir works by introducing errors into the virus’ genetic code. When enough errors are introduced, virus replication slows and the patient clears the virus.
Under less than ideal conditions — when the full dose of molnupiravir is not taken over the full period of five days, for example — the drug could lead to the creation of highly mutated, but viable, strains of SARS-CoV-2. Even under ideal conditions, patients treated with molnupiravir produced viable virus a few days into their course of treatment. The extent of the mutations which appeared due to molnupiravir are significant. In the FDA analysis of Merck’s clinical trial results, the authors note that patients who received molnupiravir showed more viral variation than those who did not, including amino acid substitutions, deletions or insertions in the spike gene, and amino acid changes were scattered throughout the coding sequence. A total of 72 emergent spike substitutions or changes was detected among 38 molnupiravir-treated patients.
In South Africa, where Omicron was first detected, molnupiravir has been taken in both ideal and non-ideal conditions. Four different South African locations were used in Merck’s clinical trial of molnupiravir, which began in October 2020. The drug was given to patients at what we now know to be the “optimal” dosage, but also at lower doses to test the drug’s efficacy in smaller amounts. There is by no means a foolproof connection between molnupiravir and Omicron, but molnupiravir is known to induce a preponderance of two types of mutations: cytosine to uridine (C→U) and guanosine to adenosine (G→A). If you look at the difference in the Omicron genome and the original Wuhan variant, these C→U and G→A mutations comprise the majority of differences, with C→U mutations more prevalent to G→A. The same has been observed for molnupiravir-induced mutations in other coronaviruses (see Figure below). Agostini et al. note that exposure to molnupiravir resulted in up to 162 mutations in MHV and 41 mutations in MERS-CoV.
She is only here to annoy herself!
https://www.medrxiv.org/content/10.1...966v3.full.pdfOur study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: -69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine
Zaštita nije neka ali i dalje postoji i to sa primarnom vakcinacijom, tj sa dvije doze.
E sad, autori ovog preprinta rade na institutu u kopenhagenu koji se bavi prevencijom i sprečavanjem zaraznih bolesti, tako da je moguće da nisu dovoljno dorasli forumaškim ekspertima.
There are currently 4 users browsing this thread. (0 members and 4 guests)
Bookmarks